Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema GYRE THERAPEUTICS INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
13.05.GYRE THERAPEUTICS, INC. - 10-Q, Quarterly Report1
09.05.Gyre Therapeutics, Inc.: Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update72Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025 U.S. IND submission to evaluate F351 for...
► Artikel lesen
08.05.GYRE THERAPEUTICS, INC. - 8-K, Current Report1
27.03.GYRE THERAPEUTICS, INC. - 10-K, Annual Report1
26.03.Gyre Therapeutics, Inc.: Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update306Data readout from Phase 3 clinical trial in the People's Republic of China ("PRC") evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical...
► Artikel lesen
21.03.GYRE THERAPEUTICS, INC. - 8-K, Current Report1
21.03.Gyre Therapeutics, Inc.: Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum2
14.02.GYRE THERAPEUTICS, INC. - 8-K, Current Report4
15.12.23GYRE THERAPEUTICS, INC. - 8-K, Current Report7
06.12.23GYRE THERAPEUTICS, INC. - 8-K, Current Report2